---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-24-000122"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:39:38.838935+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Clover Health stockholders elect directors, approve say-on-pay, ratify EY as auditor at 2024 annual meeting

## Summary
- Elected Chelsea Clinton, Carladenise Armbrister Edwards, and Vivek Garipalli as Class III directors with over 937M votes each.
- Non-binding advisory vote to approve 2023 named executive officer compensation passed with ~950.6M for vs ~11M against.
- Ratified Ernst & Young LLP as independent auditor for 2024 with ~1.1B votes for, ~5.3M against.
- Broker non-votes of ~145.2M on director election and say-on-pay proposals.

## SEC filing metadata
- accession: 0001801170-24-000122
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000122/0001801170-24-000122-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000122/clov-20240610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-24-000122
- JSON: https://secwatch.observer/filing/0001801170-24-000122.json
- Plain text: https://secwatch.observer/filing/0001801170-24-000122.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.